TCD Capital advised 3D-side, a company active at the crossroads of the patient specific protheses and the software, for a capital increase of €3.000.000. 3D-Side is a software company with direct applications in Medical 3D Imaging and 3D Printing. It provides the market with an interesting development addressing the “missing link” between the practitioners and the suppliers of medical devices and, thereby, supports a shift in the industry from generic to specific medical devices. TCD Capital federated smart investors notably with competencies in successful software companiesAt TCD Capital, we liked the competitiveness of the bundling of solutions for the value chain from imaging to printing, with the fast scale up potential of the SaaS connecting those.
Links to press release and press articles:
- De Tijd: Guido Van der Schueren investeert in MedTech (29/12/2018)
- L’Echo: Après les chirurgiens, 3D-side vise les producteurs de prothèses (14/01/2019)
- Press Release (06/06/2018)
